iifl-logo-icon 1

Wanbury Ltd Share Price

192.31
(-0.18%)
Jul 16, 2024|03:32:25 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open202.29
  • Day's High202.29
  • 52 Wk High192.66
  • Prev. Close192.66
  • Day's Low184.35
  • 52 Wk Low46.6
  • Turnover (lac)1,341.34
  • P/E20.77
  • Face Value10
  • Book Value7.04
  • EPS9.28
  • Mkt. Cap (Cr.)629.73
  • Div. Yield0
No Records Found

Wanbury Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

202.29

Prev. Close

192.66

Turnover(Lac.)

1,341.34

Day's High

202.29

Day's Low

184.35

52 Week's High

192.66

52 Week's Low

46.6

Book Value

7.04

Face Value

10

Mkt Cap (₹ Cr.)

629.73

P/E

20.77

EPS

9.28

Divi. Yield

0

Wanbury Ltd Corporate Action

7 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

26 Oct 2023

12:00 AM

BookCloser

arrow

31 Aug 2023

12:00 AM

AGM

Announcement Date: 31 Aug, 2023

arrow

20 Oct 2023

12:00 AM

EGM

arrow

Wanbury Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Wanbury Ltd SHAREHOLDING SNAPSHOT

16 Jul, 2024|12:43 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 9.23%

Foreign: 9.23%

Indian: 30.55%

Non-Promoter- 0.19%

Institutions: 0.18%

Non-Institutions: 60.02%

Custodian: 0.00%

Share Price

Wanbury Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

32.71

32.67

25.02

25

Preference Capital

0

0

0

0

Reserves

-39.96

-30.48

-155.67

-142.83

Net Worth

-7.25

2.19

-130.65

-117.83

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

392.51

367.45

371.66

433.8

yoy growth (%)

6.82

-1.13

-14.32

2.49

Raw materials

-217.14

-175.73

-174.09

-196.97

As % of sales

55.32

47.82

46.84

45.4

Employee costs

-64.14

-67.47

-87.32

-87.77

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-12.4

-17.96

-32.36

62.4

Depreciation

-9.75

-9.68

-10.3

-10.31

Tax paid

-0.2

-0.2

0.37

-0.38

Working capital

-11.56

-7.53

-58.84

-73.01

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

6.82

-1.13

-14.32

2.49

Op profit growth

-23.14

-134.75

-464.11

-42.95

EBIT growth

-28.4

-1,016.65

-101.66

294.25

Net profit growth

-119.55

-301.52

-151.57

-981.55

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

575.65

499.65

511.19

392.52

367.45

Excise Duty

0

0

0

0

0

Net Sales

575.65

499.65

511.19

392.52

367.45

Other Operating Income

0

0

0

0

0

Other Income

28.55

0.91

77.88

2.4

83.78

Wanbury Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,586.2

124.663,80,450.55867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,517.2

32.961,22,423.771,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,575.4

77.071,21,461.175310.652,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,188

34.771,19,530.541,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,794.75

26.451,13,324.081,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Wanbury Ltd

Management

Register Office

Registrar Office

Independent Director

N K Puri

Vice Chairman & Whole Time Dir

K Chandran

Company Sec. & Compli. Officer

Jitendra J Gandhi

Independent Director

Pallavi Shedge

Independent Director

Pravin Dilip Pawar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Honble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/- each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.Th
Read More

Company FAQs

What is the Wanbury Ltd share price today?

Down Arrow

The Wanbury Ltd shares price on N/A is Rs.₹190.55 today.

What is the Market Cap of Wanbury Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Wanbury Ltd is ₹623.97 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Wanbury Ltd?

Down Arrow

The PE and PB ratios of Wanbury Ltd is 20.77 and 22.68 as of 16 Jul ‘24

What is the 52 Week High and Low of Wanbury Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Wanbury Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Wanbury Ltd is ₹46.56 and ₹192.75 as of 16 Jul ‘24

What is the CAGR of Wanbury Ltd?

Down Arrow

Wanbury Ltd's CAGR for 5 Years at 68.19%, 3 Years at 30.02%, 1 Year at 298.33%, 6 Month at 40.44%, 3 Month at 27.86% and 1 Month at 17.85%.

What is the shareholding pattern of Wanbury Ltd?

Down Arrow

The shareholding pattern of Wanbury Ltd is as follows:
Promoters - 39.79 %
Institutions - 0.18 %
Public - 60.03 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.